Cloxazolam
(Redirected from Sepazon)
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Akton, Cloxam, Clozal, Elum, Olcadil, and Sepazon[1] |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 65 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H14Cl2N2O2 |
| Molar mass | 349.21 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties.[3][4] It is not widely used; [3] as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan.[1] In 2019, it has been retired from the Belgian market. [5]
See also
[edit]References
[edit]- ^ a b "Cloxazolam International Brands". Drugs.com. Retrieved 13 August 2018.
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ a b Stolerman IP, ed. (2010). "C: Cloxazolam". Encyclopedia of Psychopharmacology. Berlin: Springer-Verlag. ISBN 978-3-540-68706-1.
- ^ Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1: CD008922. doi:10.1002/14651858.CD008922.pub2. PMID 22258993. S2CID 73769165.
- ^ "Bon à savoir". cbip.be. Retrieved 13 August 2018.